iRhythm Technologies, Inc. (IRTC) vs Tango Therapeutics, Inc. (TNGX)
A side-by-side comparison of iRhythm Technologies, Inc. and Tango Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IRTC
iRhythm Technologies, Inc.
$107.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNGX
Tango Therapeutics, Inc.
$21.90HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IRTC vs TNGX
growth of $100 · dividends reinvested · last 6yIRTC -51.9% (-11.5%/yr)TNGX +125.6% (+14.5%/yr)TNGX compounded faster over this window
IRTC TNGX
IRTC vs TNGX: by the numbers
- •TNGX is the larger company ($3.57B vs $3.52B market cap).
- •Both run net losses; IRTC's is the smaller (-1.69% vs -229.92% net margin).
- •IRTC grew revenue faster over the past five years (21.93% vs 19.14% CAGR).
Metrics side by side
Valuation
| Metric | IRTC | TNGX |
|---|---|---|
| P/S ratio | 4.27 | 66.26 |
| P/B ratio | 18.94 | 3.48 |
| EV / EBITDA | 286.35 | N/A |
| FCF yield | 1.11% | N/A |
Profitability
| Metric | IRTC | TNGX |
|---|---|---|
| Gross margin | 71.45% | 98.25% |
| Operating margin | -1.17% | -178.39% |
| Net margin | -1.69% | -229.92% |
| ROE | -7.50% | -12.08% |
| ROIC | -1.07% | -12.91% |
Growth (annualized)
| Metric | IRTC | TNGX |
|---|---|---|
| Revenue CAGR (5Y) | 21.93% | 19.14% |
| Total return CAGR (5Y) | 12.95% | 10.60% |
Frequently asked
- Which has grown faster, IRTC or TNGX?
- Over the past five years, IRTC grew revenue faster — IRTC at a 21.93% CAGR versus TNGX at 19.14%.
- How have IRTC and TNGX total returns compared?
- Over the past 5 years, IRTC delivered 12.95% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
iRhythm Technologies ROETango Therapeutics ROEiRhythm Technologies operating marginTango Therapeutics operating marginiRhythm Technologies revenue growthTango Therapeutics revenue growthiRhythm Technologies free cash flowTango Therapeutics free cash flow
iRhythm Technologies & Tango Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.